The present invention provides compounds of Formula I, or pharmaceutically acceptable salts thereof, that are inhibitors of voltage-gated sodium channels, in particular Nav 1.7. The compounds are useful for the treatment of diseases treatable by inhibition of sodium channels such as pain disorders. Also provided are pharmaceutical compositions containing compounds of the present invention.
本发明提供了I式化合物或其药学上可接受的盐,它们是电压门控
钠通道的
抑制剂,特别是Nav 1.7。这些化合物对于治疗可通过
钠通道抑制治疗的疾病如疼痛障碍非常有用。还提供了包含本发明化合物的制药组合物。